CSBR:NASDAQ
Champions Oncology Inc
4,34 US$
arrow_downward
-1,36%(-0,060) 1K
20-noy, 16:00:00 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoCSBR tikeri uchun statistika yaratilmoqda...
Ochish
4,45 US$
Yuqori
4,45 US$
Past
4,34 US$
Bozor kapitali
60,41 mln
Oʻrtacha hajm
6,97 ming
Hajmi
8,94 ming
52 haftalik eng yuqori
8,31 US$
52 haftalik eng past
4,34 US$
Aksiya boʻyicha daromad
-0,08 US$
Beta
0,47
Muomaladagi aksiyalar
13,92 mln
Xodimlar soni
217
Ochish
4,45 US$
Yuqori
4,45 US$
Past
4,34 US$
Bozor kapitali
60,41 mln
Oʻrtacha hajm
6,97 ming
Hajmi
8,94 ming
52 haftalik eng yuqori
8,31 US$
52 haftalik eng past
4,34 US$
Aksiya boʻyicha daromad
-0,08 US$
Beta
0,47
Muomaladagi aksiyalar
13,92 mln
Xodimlar soni
217
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
AP News
·
2 soat oldin
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
The Motley Fool
·
1 soat oldin
Report: Goldman Sachs Predicts the S&P 500 Will Gain 26% in 12 Months
WSJ
·
15 soat oldin
S&P 500 Flirts With Correction
Profil
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
Champions Oncology Inc haqida
CEO-
Xodimlar soni217
Asos solingan2007
Bosh ofislarHackensack, N'yu-Jersi, Amerika Qo‘shma Shtatlari
SektorHealth Care
Soha-
Veb-saytchampionsoncology.com